| 1. | thegoldbug | |
| 2. | ladygodiva9293 | |
| 3. | renysion | |
| 4. | 49bjoe | |
| 5. | dddimensions |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | davsdu94 02/14/2018 up 11.02%. |
| 2. | thegoldbug 02/26/2018 Another biotech winner so far in 2018, up 50% so far. |
| 3. | dddimensions 04/25/2018 New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors |
| 4. | 49bjoe 04/11/2018 Company has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and saf… |
| 5. | nomercjr 05/14/2018 Canaccord Genuity sets PT at $94 |
| 6. | ladygodiva9293 06/04/2018 H.C. Wainwright Slashes Price Target on Nektar Therapeutics (NKTR), Says 'Optimism Has Been Eroded' |
| 7. | ladygodiva9293 04/11/2018 News!!!!! |
| 8. | thegoldbug 04/16/2018 Intriguing news. |
| 9. | 49bjoe 04/13/2018 Piper Jaffray resumes coverage as an overweight, $125PT |
| 10. | renysion 04/11/2018 I'm a buyer again |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Nektar Therapeutics
- NKTR
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.